{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Anaheim",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "95132",
      "recalling_firm": "Preferred Pharmaceuticals, Inc.",
      "address_1": "1250 N Lakeview Ave Ste O",
      "address_2": "",
      "postal_code": "92807-1801",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "CA and NV",
      "recall_number": "D-0647-2024",
      "product_description": "Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories, Louisiana, Shreveport, NDC 68788-9110-03.",
      "product_quantity": "266 bottles",
      "reason_for_recall": "Failed Impurities/Degradation Specifications - at 18-month Stability testing",
      "recall_initiation_date": "20240808",
      "center_classification_date": "20240826",
      "report_date": "20240904",
      "code_info": "Lot: B0223H, Exp: 5/31/2026; C3023H, Exp: 9/30/2026.",
      "more_code_info": ""
    }
  ]
}